Zhenzhen Liu

6.7k total citations · 1 hit paper
280 papers, 4.5k citations indexed

About

Zhenzhen Liu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Zhenzhen Liu has authored 280 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 107 papers in Molecular Biology, 94 papers in Oncology and 78 papers in Cancer Research. Recurrent topics in Zhenzhen Liu's work include Breast Cancer Treatment Studies (35 papers), HER2/EGFR in Cancer Research (27 papers) and Cancer Treatment and Pharmacology (21 papers). Zhenzhen Liu is often cited by papers focused on Breast Cancer Treatment Studies (35 papers), HER2/EGFR in Cancer Research (27 papers) and Cancer Treatment and Pharmacology (21 papers). Zhenzhen Liu collaborates with scholars based in China, United States and Denmark. Zhenzhen Liu's co-authors include Paul A. Roche, Xue‐Feng Bai, Dechuang Jiao, Shude Cui, Jin-Qing Liu, Fatemeh Talebian, Jianghua Qiao, Min Yan, Yongjun Yang and Xinning Zhang and has published in prestigious journals such as Journal of the American Chemical Society, Nucleic Acids Research and Nature Communications.

In The Last Decade

Zhenzhen Liu

265 papers receiving 4.5k citations

Hit Papers

Macropinocytosis in phago... 2015 2026 2018 2022 2015 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Macropinocytosis in phagocytes: regulation of MHC class-II-restricted antigen presentation in dendritic cells
    2015 464 citations Zhenzhen Liu et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhenzhen Liu China 34 1.9k 966 913 715 397 280 4.5k
Min He China 37 1.8k 0.9× 885 0.9× 715 0.8× 684 1.0× 384 1.0× 243 4.6k
Min Luo China 36 2.3k 1.2× 706 0.7× 663 0.7× 665 0.9× 355 0.9× 206 4.9k
Jing Hu China 32 1.9k 1.0× 627 0.6× 825 0.9× 429 0.6× 377 0.9× 175 3.9k
Juan Su China 38 2.8k 1.5× 770 0.8× 769 0.8× 940 1.3× 289 0.7× 298 5.4k
Yongzhong Wu China 29 1.8k 0.9× 989 1.0× 820 0.9× 1.2k 1.6× 478 1.2× 109 4.3k
Ajaz A. Bhat India 32 2.4k 1.3× 838 0.9× 1.0k 1.1× 504 0.7× 444 1.1× 125 4.8k
Ji‐Ye Yin China 41 2.7k 1.4× 1.1k 1.1× 1.3k 1.4× 523 0.7× 642 1.6× 197 5.1k
Kui Zhang China 37 2.4k 1.2× 600 0.6× 740 0.8× 794 1.1× 465 1.2× 188 4.5k
Mingzhu Yin China 34 3.0k 1.6× 927 1.0× 801 0.9× 854 1.2× 381 1.0× 140 6.1k
Dragana Nikitovic Greece 42 2.7k 1.4× 786 0.8× 768 0.8× 484 0.7× 344 0.9× 122 6.0k

Countries citing papers authored by Zhenzhen Liu

Since Specialization
Citations

This map shows the geographic impact of Zhenzhen Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenzhen Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenzhen Liu more than expected).

Fields of papers citing papers by Zhenzhen Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhenzhen Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenzhen Liu. The network helps show where Zhenzhen Liu may publish in the future.

Co-authorship network of co-authors of Zhenzhen Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhenzhen Liu. A scholar is included among the top collaborators of Zhenzhen Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhenzhen Liu. Zhenzhen Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yan, Min, Xinlan Liu, Shusen Wang, et al.. (2025). Utidelone Plus Bevacizumab for ERBB2-Negative Metastatic Breast Cancer and Active Brain Metastases. JAMA Oncology. 11(8). 883–883. 1 indexed citations
2.
Zhang, Yilei, Zhenzhen Liu, Yuhan Zhou, et al.. (2024). Prevalence and molecular characterization of Trichomonas gallinae from pigeons in Anhui, China. Comparative Immunology Microbiology and Infectious Diseases. 107. 102157–102157. 5 indexed citations
3.
Zhang, Jiao, Xixi He, Xuhui Guo, et al.. (2024). Identification potential biomarkers for diagnosis, and progress of breast cancer by using high-pressure photon ionization time-of-flight mass spectrometry. Analytica Chimica Acta. 1320. 342883–342883. 4 indexed citations
4.
Liu, Zhenzhen, et al.. (2024). Dihydroartemisinin is an inhibitor of trained immunity through Akt/mTOR/HIF1α signaling pathway. Experimental Cell Research. 438(1). 114052–114052. 2 indexed citations
5.
6.
Ma, Wei, et al.. (2023). Antibacterial Activity of Thesium chinense Turcz Extract Against Bacteria Associated with Upper Respiratory Tract Infections. Infection and Drug Resistance. Volume 16. 5091–5105. 6 indexed citations
7.
Ye, Mengxiang, Huaimeng Li, Zhenzhen Liu, et al.. (2023). Fe/Fe3C nanoparticles embedded in N-doped porous carbon as the heterogeneous electro-Fenton catalyst for efficient degradation of bisphenol A. Separation and Purification Technology. 316. 123778–123778. 33 indexed citations
8.
9.
Yan, Min, Limin Niu, Mengwei Zhang, et al.. (2023). Dalpiciclib and pyrotinib in women with HER2-positive advanced breast cancer: a single-arm phase II trial. Nature Communications. 14(1). 6272–6272. 7 indexed citations
10.
Yuan, Peng, et al.. (2023). Impact of residual disease biomarkers on the prognosis of HER2‐positive breast cancer following neoadjuvant therapy. Cancer Medicine. 12(10). 11293–11304. 8 indexed citations
11.
12.
Liu, Zhenzhen, et al.. (2023). Clinicopathological features of gastric adenocarcinoma of fundic gland type. World Chinese Journal of Digestology. 31(6). 244–248.
13.
Liu, Zhenzhen, Cun-Xian Jia, & Xianchen Liu. (2022). Excessive daytime sleepiness mediates the relationship between insomnia symptoms and suicidal behavior in adolescents. SLEEP. 45(11). 7 indexed citations
14.
Yang, Yaping, Jieqiong Liu, Min Peng, et al.. (2020). Introduction of a multicenter online database for non-metastatic breast cancer in China. Science China Life Sciences. 63(9). 1417–1420. 9 indexed citations
15.
16.
Zhang, Xiaolei, et al.. (2020). Acupuncture and related therapies for stable angina pectoris. Medicine. 99(51). e23756–e23756. 2 indexed citations
17.
Liu, Zhenzhen, et al.. (2017). Effects of health information literacy on ability of network knowledge acquisition among breast cancer patients. Zhonghua xiandai huli zazhi. 23(3). 362–367. 1 indexed citations
18.
Qiao, Jianghua, et al.. (2015). Clinical significance of topoisomerase 2A expression and gene change in operable invasive breast cancer. Tumor Biology. 36(9). 6833–6838. 16 indexed citations
19.
Yan, Min, Huimin Lü, Zhenzhen Liu, et al.. (2013). High risk factors of brain metastases in 295 patients with advanced breast cancer. Chinese Medical Journal. 126(7). 1269–1275. 14 indexed citations
20.
Deng, Yanfei, Qingyou Liu, Chan Luo, et al.. (2012). Generation of Induced Pluripotent Stem Cells From Buffalo ( Bubalus bubalis ) Fetal Fibroblasts with Buffalo Defined Factors. Stem Cells and Development. 21(13). 2485–2494. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Min He Breakdown of academic impact, for papers by Min Luo Breakdown of academic impact, for papers by Jing Hu Breakdown of academic impact, for papers by Juan Su Breakdown of academic impact, for papers by Yongzhong Wu Breakdown of academic impact, for papers by Ajaz A. Bhat Breakdown of academic impact, for papers by Ji‐Ye Yin Breakdown of academic impact, for papers by Kui Zhang Breakdown of academic impact, for papers by Mingzhu Yin Breakdown of academic impact, for papers by Dragana Nikitovic
Rankless by CCL
2026